Switch theme
Sign up to access all valuation multiples
Draegerwerk AG & Co KGaA develops medical and safety equipment for clinical and industrial applications. The firm operates in two segments: medical and safety. The medical division contributes the majority of revenue, it develops and produces system solutions, equipment, and services for the acute point of care, it has five business units Therapy, Hospital Consumables & Accessories, Workplace Infrastructure, Monitoring, and Data Business. Its safety division develops and produces devices, system solutions, and services for personal protection, gas detection, and integrated hazard management. Its geographical segments are Europe; Germany; the Americas; Africa, Asia, and Australia.
1889
16.6K+
LTM Revenue $3.9B
LTM EBITDA $374M
$1.4B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Draegerwerk has a last 12-month revenue (LTM) of $3.9B and a last 12-month EBITDA of $374M.
In the most recent fiscal year, Draegerwerk achieved revenue of $3.8B and an EBITDA of $227M.
Draegerwerk expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Draegerwerk valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $3.9B | XXX | $3.8B | XXX | XXX | XXX |
| Gross Profit | $1.7B | XXX | $1.7B | XXX | XXX | XXX |
| Gross Margin | 45% | XXX | 45% | XXX | XXX | XXX |
| EBITDA | $374M | XXX | $227M | XXX | XXX | XXX |
| EBITDA Margin | 10% | XXX | 6% | XXX | XXX | XXX |
| EBIT | $211M | XXX | $202M | XXX | XXX | XXX |
| EBIT Margin | 5% | XXX | 5% | XXX | XXX | XXX |
| Net Profit | $134M | XXX | $140M | XXX | XXX | XXX |
| Net Margin | 3% | XXX | 4% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $54.2M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Draegerwerk's stock price is EUR 61 (or $68).
Draegerwerk has current market cap of EUR 1.1B (or $1.3B), and EV of EUR 1.3B (or $1.4B).
See Draegerwerk trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.4B | $1.3B | XXX | XXX | XXX | XXX | $6.73 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Draegerwerk has market cap of $1.3B and EV of $1.4B.
Draegerwerk's trades at 0.4x EV/Revenue multiple, and 6.3x EV/EBITDA.
Equity research analysts estimate Draegerwerk's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Draegerwerk has a P/E ratio of 9.5x.
See valuation multiples for Draegerwerk and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1.3B | XXX | $1.3B | XXX | XXX | XXX |
| EV (current) | $1.4B | XXX | $1.4B | XXX | XXX | XXX |
| EV/Revenue | 0.4x | XXX | 0.4x | XXX | XXX | XXX |
| EV/EBITDA | 3.8x | XXX | 6.3x | XXX | XXX | XXX |
| EV/EBIT | 6.8x | XXX | 7.1x | XXX | XXX | XXX |
| EV/Gross Profit | 0.8x | XXX | n/a | XXX | XXX | XXX |
| P/E | 9.5x | XXX | 9.1x | XXX | XXX | XXX |
| EV/FCF | 9.6x | XXX | 12.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialDraegerwerk's last 12 month revenue growth is 4%
Draegerwerk's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Draegerwerk's rule of 40 is 9% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Draegerwerk's rule of X is 19% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Draegerwerk and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 4% | XXX | 4% | XXX | XXX | XXX |
| EBITDA Margin | 10% | XXX | 6% | XXX | XXX | XXX |
| EBITDA Growth | 2% | XXX | 38% | XXX | XXX | XXX |
| Rule of 40 | 9% | XXX | 10% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 19% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 22% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 10% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 40% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Draegerwerk acquired XXX companies to date.
Last acquisition by Draegerwerk was XXXXXXXX, XXXXX XXXXX XXXXXX . Draegerwerk acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Draegerwerk founded? | Draegerwerk was founded in 1889. |
| Where is Draegerwerk headquartered? | Draegerwerk is headquartered in Germany. |
| How many employees does Draegerwerk have? | As of today, Draegerwerk has 16.6K+ employees. |
| Is Draegerwerk publicy listed? | Yes, Draegerwerk is a public company listed on ETR. |
| What is the stock symbol of Draegerwerk? | Draegerwerk trades under DRW8 ticker. |
| When did Draegerwerk go public? | Draegerwerk went public in 1979. |
| Who are competitors of Draegerwerk? | Similar companies to Draegerwerk include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Draegerwerk? | Draegerwerk's current market cap is $1.3B |
| What is the current revenue of Draegerwerk? | Draegerwerk's last 12 months revenue is $3.9B. |
| What is the current revenue growth of Draegerwerk? | Draegerwerk revenue growth (NTM/LTM) is 4%. |
| What is the current EV/Revenue multiple of Draegerwerk? | Current revenue multiple of Draegerwerk is 0.4x. |
| Is Draegerwerk profitable? | Yes, Draegerwerk is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Draegerwerk? | Draegerwerk's last 12 months EBITDA is $374M. |
| What is Draegerwerk's EBITDA margin? | Draegerwerk's last 12 months EBITDA margin is 10%. |
| What is the current EV/EBITDA multiple of Draegerwerk? | Current EBITDA multiple of Draegerwerk is 3.8x. |
| What is the current FCF of Draegerwerk? | Draegerwerk's last 12 months FCF is $150M. |
| What is Draegerwerk's FCF margin? | Draegerwerk's last 12 months FCF margin is 4%. |
| What is the current EV/FCF multiple of Draegerwerk? | Current FCF multiple of Draegerwerk is 9.6x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
